What is the size of the intravenous solutions market in 2021?

The intravenous solutions market size is US$ 12,641 million in 2021.

What is the projected CAGR at which the intravenous solutions market is expected to grow at?

The intravenous solutions market is expected to grow at a CAGR of 7.6% (2023-2032).

List the segments encompassed in this report on the intravenous solutions market?

market.US has segmented the intravenous solutions market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product, the market has been further divided into Total Parenteral Nutrition and Peripheral Parenteral Nutrition. By Nutrient, the market has been further divided into Carbohydrates Parenteral Lipid Emulsion, Vitamins and Minerals, Single Dose Amino Acids, and Other Nutrients.

List the key industry players of the intravenous solutions market?

Fresenius Kabi AG, Pfizer, Inc., Otsuka Pharmaceutical Co., Ltd., Baxter, B. Braun Melsungen AG, Vifor Pharma Management Ltd., JW Life Science, Amanta Healthcare, ICU Medical Inc., Grifols, S.A., and Other Key Players engaged in the Intravenous Solutions market.

Which region is more appealing for vendors employed in the intravenous solutions market?

North America is expected to account for the highest revenue share of 42.3%. Therefore, the intravenous solutions industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for intravenous solutions?

The US, India, China, Canada, UK, Japan, & Germany are key areas of operation for the intravenous solutions market.

Which segment accounts for the greatest market share in the intravenous solutions industry?

With respect to the intravenous solutions industry, vendors can expect to leverage greater prospective business opportunities through the total parenteral nutrition segment, as this area of interest accounts for the largest market share.

Global Intravenous Solutions Market By Product (Total Parenteral Nutrition and Peripheral Parenteral Nutrition), By Nutrient (Carbohydrates, Parenteral Lipid Emulsion, and Others), By Region and Companies - Industry Segment Outlook, market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Published date: Nov 2021
Report ID: 21117
Number of Pages: 267
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
  - 1.4. Key Analysis
  - 1.5. Key Findings by Major Segments
  - 1.6. Top strategies by Major Players
- 2. Global Intravenous Solutions Overview
  - 2.1. Intravenous Solutions Dynamics
    2.1.1. Drivers
    2.1.2. Opportunities
    2.1.3. Restraints
    2.1.4. Challenges
  - 2.2. Macro-economic Factors
  - 2.3. Regulatory Framework
  - 2.4. Market Investment Feasibility Index
  - 2.5. PEST Analysis
  - 2.6. PORTER’S Five Force Analysis
  - 2.7. Drivers & Restraints Impact Analysis
  - 2.8. Industry Chain Analysis
  - 2.9. Cost Structure Analysis
  - 2.10. Marketing Strategy
  - 2.11. Russia-Ukraine War Impact Analysis
  - 2.12. Opportunity Map Analysis
  - 2.13. Market Competition Scenario Analysis
  - 2.14. Product Life Cycle Analysis
  - 2.15. Opportunity Orbits
  - 2.16. Manufacturer Intensity Map
  - 2.17. Major Companies sales by Value & Volume
- 3. Global Intravenous Solutions Analysis, Opportunity and Forecast, 2016-2032
  - 3.1. Global Intravenous Solutions Analysis, 2016-2021
  - 3.2. Global Intravenous Solutions Opportunity and Forecast, 2023-2032
  - 3.3. Global Intravenous Solutions Analysis, Opportunity and Forecast, By Product, 2016-2032
    3.3.1. Global Intravenous Solutions Analysis by Product: Introduction
    3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
    3.3.3. Total Parenteral Nutrition
    3.3.4. Peripheral Parenteral Nutrition
  - 3.4. Global Intravenous Solutions Analysis, Opportunity and Forecast, By Nutrient, 2016-2032
    3.4.1. Global Intravenous Solutions Analysis by Nutrient: Introduction
    3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Nutrient, 2016-2032
    3.4.3. Carbohydrates
    3.4.4. Parenteral Lipid Emulsion
    3.4.5. Vitamins and Minerals
    3.4.6. Single Dose Amino Acids
    3.4.7. Other Nutrients
- 4. North America Intravenous Solutions Analysis, Opportunity and Forecast, 2016-2032
  - 4.1. North America Intravenous Solutions Analysis, 2016-2021
  - 4.2. North America Intravenous Solutions Opportunity and Forecast, 2023-2032
  - 4.3. North America Intravenous Solutions Analysis, Opportunity and Forecast, By Product, 2016-2032
    4.3.1. North America Intravenous Solutions Analysis by Product: Introduction
    4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
    4.3.3. Total Parenteral Nutrition
    4.3.4. Peripheral Parenteral Nutrition
  - 4.4. North America Intravenous Solutions Analysis, Opportunity and Forecast, By Nutrient, 2016-2032
    4.4.1. North America Intravenous Solutions Analysis by Nutrient: Introduction
    4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Nutrient, 2016-2032
    4.4.3. Carbohydrates
    4.4.4. Parenteral Lipid Emulsion
    4.4.5. Vitamins and Minerals
    4.4.6. Single Dose Amino Acids
    4.4.7. Other Nutrients
  - 4.5. North America Intravenous Solutions Analysis, Opportunity and Forecast, By Country , 2016-2032
    4.5.1. North America Intravenous Solutions Analysis by Country : Introduction
    4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    4.5.2.1. U.S.
    4.5.2.2. Canada
    4.5.2.3. Mexico
- 5. Europe Intravenous Solutions Analysis, Opportunity and Forecast, 2016-2032
  - 5.1. Europe Intravenous Solutions Analysis, 2016-2021
  - 5.2. Europe Intravenous Solutions Opportunity and Forecast, 2023-2032
  - 5.3. Europe Intravenous Solutions Analysis, Opportunity and Forecast, By Product, 2016-2032
    5.3.1. Europe Intravenous Solutions Analysis by Product: Introduction
    5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
    5.3.3. Total Parenteral Nutrition
    5.3.4. Peripheral Parenteral Nutrition
  - 5.4. Europe Intravenous Solutions Analysis, Opportunity and Forecast, By Nutrient, 2016-2032
    5.4.1. Europe Intravenous Solutions Analysis by Nutrient: Introduction
    5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Nutrient, 2016-2032
    5.4.3. Carbohydrates
    5.4.4. Parenteral Lipid Emulsion
    5.4.5. Vitamins and Minerals
    5.4.6. Single Dose Amino Acids
    5.4.7. Other Nutrients
  - 5.5. Europe Intravenous Solutions Analysis, Opportunity and Forecast, By Country , 2016-2032
    5.5.1. Europe Intravenous Solutions Analysis by Country : Introduction
    5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    5.5.2.1. U.K.
    5.5.2.2. Germany
    5.5.2.3. France
    5.5.2.4. Spain
    5.5.2.5. Italy
    5.5.2.6. Russia
    5.5.2.7. Rest of Europe
- 6. Asia-Pacific Intravenous Solutions Analysis, Opportunity and Forecast, 2016-2032
  - 6.1. Asia-Pacific Intravenous Solutions Analysis, 2016-2021
  - 6.2. Asia-Pacific Intravenous Solutions Opportunity and Forecast, 2023-2032
  - 6.3. Asia-Pacific Intravenous Solutions Analysis, Opportunity and Forecast, By Product, 2016-2032
    6.3.1. Asia-Pacific Intravenous Solutions Analysis by Product: Introduction
    6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
    6.3.3. Total Parenteral Nutrition
    6.3.4. Peripheral Parenteral Nutrition
  - 6.4. Asia-Pacific Intravenous Solutions Analysis, Opportunity and Forecast, By Nutrient, 2016-2032
    6.4.1. Asia-Pacific Intravenous Solutions Analysis by Nutrient: Introduction
    6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Nutrient, 2016-2032
    6.4.3. Carbohydrates
    6.4.4. Parenteral Lipid Emulsion
    6.4.5. Vitamins and Minerals
    6.4.6. Single Dose Amino Acids
    6.4.7. Other Nutrients
  - 6.5. Asia-Pacific Intravenous Solutions Analysis, Opportunity and Forecast, By Country , 2016-2032
    6.5.1. Asia-Pacific Intravenous Solutions Analysis by Country : Introduction
    6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    6.5.2.1. China
    6.5.2.2. Japan
    6.5.2.3. South Korea
    6.5.2.4. India
    6.5.2.5. Rest of Asia-Pacific
- 7. South America Intravenous Solutions Analysis, Opportunity and Forecast, 2016-2032
  - 7.1. South America Intravenous Solutions Analysis, 2016-2021
  - 7.2. South America Intravenous Solutions Opportunity and Forecast, 2023-2032
  - 7.3. South America Intravenous Solutions Analysis, Opportunity and Forecast, By Product, 2016-2032
    7.3.1. South America Intravenous Solutions Analysis by Product: Introduction
    7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
    7.3.3. Total Parenteral Nutrition
    7.3.4. Peripheral Parenteral Nutrition
  - 7.4. South America Intravenous Solutions Analysis, Opportunity and Forecast, By Nutrient, 2016-2032
    7.4.1. South America Intravenous Solutions Analysis by Nutrient: Introduction
    7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Nutrient, 2016-2032
    7.4.3. Carbohydrates
    7.4.4. Parenteral Lipid Emulsion
    7.4.5. Vitamins and Minerals
    7.4.6. Single Dose Amino Acids
    7.4.7. Other Nutrients
  - 7.5. South America Intravenous Solutions Analysis, Opportunity and Forecast, By Country , 2016-2032
    7.5.1. South America Intravenous Solutions Analysis by Country : Introduction
    7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    7.5.2.1. Brazil
    7.5.2.2. Argentina
    7.5.2.3. Rest of South America
- 8. Middle East and Africa Intravenous Solutions Analysis, Opportunity and Forecast, 2016-2032
  - 8.1. Middle East and Africa Intravenous Solutions Analysis, 2016-2021
  - 8.2. Middle East and Africa Intravenous Solutions Opportunity and Forecast, 2023-2032
  - 8.3. Middle East and Africa Intravenous Solutions Analysis, Opportunity and Forecast, By Product, 2016-2032
    8.3.1. Middle East and Africa Intravenous Solutions Analysis by Product: Introduction
    8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product, 2016-2032
    8.3.3. Total Parenteral Nutrition
    8.3.4. Peripheral Parenteral Nutrition
  - 8.4. Middle East and Africa Intravenous Solutions Analysis, Opportunity and Forecast, By Nutrient, 2016-2032
    8.4.1. Middle East and Africa Intravenous Solutions Analysis by Nutrient: Introduction
    8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Nutrient, 2016-2032
    8.4.3. Carbohydrates
    8.4.4. Parenteral Lipid Emulsion
    8.4.5. Vitamins and Minerals
    8.4.6. Single Dose Amino Acids
    8.4.7. Other Nutrients
  - 8.5. Middle East and Africa Intravenous Solutions Analysis, Opportunity and Forecast, By Country , 2016-2032
    8.5.1. Middle East and Africa Intravenous Solutions Analysis by Country : Introduction
    8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    8.5.2.1. GCC
    8.5.2.2. Israel
    8.5.2.3. South Africa
    8.5.2.4. Rest of MEA
- 9. Global Intravenous Solutions Analysis, Opportunity and Forecast, By Region , 2016-2032
  - 9.1. Global Intravenous Solutions Analysis by Region : Introduction
  - 9.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
    9.2.1. North America
    9.2.2. Europe
    9.2.3. Asia-Pacific
    9.2.4. South America
    9.2.5. Middle East and Africa
- 10. Global Intravenous Solutions Competitive Landscape, Market Share Analysis, and Company Profiles
  - 10.1. Market Share Analysis
  - 10.2. Company Profiles
  - 10.3. Fresenius Kabi AG
    10.3.1. Company Overview
    10.3.2. Financial Highlights
    10.3.3. Product Portfolio
    10.3.4. SWOT Analysis
    10.3.5. Key Strategies and Developments
  - 10.4. Pfizer, Inc.
    10.4.1. Company Overview
    10.4.2. Financial Highlights
    10.4.3. Product Portfolio
    10.4.4. SWOT Analysis
    10.4.5. Key Strategies and Developments
  - 10.5. Otsuka Pharmaceutical Co., Ltd.
    10.5.1. Company Overview
    10.5.2. Financial Highlights
    10.5.3. Product Portfolio
    10.5.4. SWOT Analysis
    10.5.5. Key Strategies and Developments
  - 10.6. Baxter
    10.6.1. Company Overview
    10.6.2. Financial Highlights
    10.6.3. Product Portfolio
    10.6.4. SWOT Analysis
    10.6.5. Key Strategies and Developments
  - 10.7. B. Braun Melsungen AG
    10.7.1. Company Overview
    10.7.2. Financial Highlights
    10.7.3. Product Portfolio
    10.7.4. SWOT Analysis
    10.7.5. Key Strategies and Developments
  - 10.8. Vifor Pharma Management Ltd.
    10.8.1. Company Overview
    10.8.2. Financial Highlights
    10.8.3. Product Portfolio
    10.8.4. SWOT Analysis
    10.8.5. Key Strategies and Developments
  - 10.9. JW Life Science
    10.9.1. Company Overview
    10.9.2. Financial Highlights
    10.9.3. Product Portfolio
    10.9.4. SWOT Analysis
    10.9.5. Key Strategies and Developments
  - 10.10. Amanta Healthcare
    10.10.1. Company Overview
    10.10.2. Financial Highlights
    10.10.3. Product Portfolio
    10.10.4. SWOT Analysis
    10.10.5. Key Strategies and Developments
  - 10.11. ICU Medical Inc.
    10.11.1. Company Overview
    10.11.2. Financial Highlights
    10.11.3. Product Portfolio
    10.11.4. SWOT Analysis
    10.11.5. Key Strategies and Developments
  - 10.12. Grifols, S.A.
    10.12.1. Company Overview
    10.12.2. Financial Highlights
    10.12.3. Product Portfolio
    10.12.4. SWOT Analysis
    10.12.5. Key Strategies and Developments
  - 10.13. Other Key Players
    10.13.1. Company Overview
    10.13.2. Financial Highlights
    10.13.3. Product Portfolio
    10.13.4. SWOT Analysis
    10.13.5. Key Strategies and Developments
- 11. Assumptions and Acronyms
- 12. Research Methodology
- 13. Contact
- List of Figures
  - Figure 1: Global Intravenous Solutions Revenue (US$ Mn) Market Share by Product in 2022
  - Figure 2: Global Intravenous Solutions Market Attractiveness Analysis by Product, 2016-2032
  - Figure 3: Global Intravenous Solutions Revenue (US$ Mn) Market Share by Nutrientin 2022
  - Figure 4: Global Intravenous Solutions Market Attractiveness Analysis by Nutrient, 2016-2032
  - Figure 5: Global Intravenous Solutions Revenue (US$ Mn) Market Share by Region in 2022
  - Figure 6: Global Intravenous Solutions Market Attractiveness Analysis by Region, 2016-2032
  - Figure 7: Global Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Figure 8: Global Intravenous Solutions Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Figure 9: Global Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Figure 10: Global Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Figure 11: Global Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
  - Figure 12: Global Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Figure 13: Global Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Figure 14: Global Intravenous Solutions Market Share Comparison by Region (2016-2032)
  - Figure 15: Global Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Figure 16: Global Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Figure 17: North America Intravenous Solutions Revenue (US$ Mn) Market Share by Productin 2022
  - Figure 18: North America Intravenous Solutions Market Attractiveness Analysis by Product, 2016-2032
  - Figure 19: North America Intravenous Solutions Revenue (US$ Mn) Market Share by Nutrientin 2022
  - Figure 20: North America Intravenous Solutions Market Attractiveness Analysis by Nutrient, 2016-2032
  - Figure 21: North America Intravenous Solutions Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 22: North America Intravenous Solutions Market Attractiveness Analysis by Country, 2016-2032
  - Figure 23: North America Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Figure 24: North America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 25: North America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Figure 26: North America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Figure 27: North America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 28: North America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Figure 29: North America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Figure 30: North America Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Figure 31: North America Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Figure 32: North America Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Figure 33: Europe Intravenous Solutions Revenue (US$ Mn) Market Share by Productin 2022
  - Figure 34: Europe Intravenous Solutions Market Attractiveness Analysis by Product, 2016-2032
  - Figure 35: Europe Intravenous Solutions Revenue (US$ Mn) Market Share by Nutrientin 2022
  - Figure 36: Europe Intravenous Solutions Market Attractiveness Analysis by Nutrient, 2016-2032
  - Figure 37: Europe Intravenous Solutions Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 38: Europe Intravenous Solutions Market Attractiveness Analysis by Country, 2016-2032
  - Figure 39: Europe Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Figure 40: Europe Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 41: Europe Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Figure 42: Europe Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Figure 43: Europe Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 44: Europe Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Figure 45: Europe Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Figure 46: Europe Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Figure 47: Europe Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Figure 48: Europe Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Figure 49: Asia-Pacific Intravenous Solutions Revenue (US$ Mn) Market Share by Productin 2022
  - Figure 50: Asia-Pacific Intravenous Solutions Market Attractiveness Analysis by Product, 2016-2032
  - Figure 51: Asia-Pacific Intravenous Solutions Revenue (US$ Mn) Market Share by Nutrientin 2022
  - Figure 52: Asia-Pacific Intravenous Solutions Market Attractiveness Analysis by Nutrient, 2016-2032
  - Figure 53: Asia-Pacific Intravenous Solutions Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 54: Asia-Pacific Intravenous Solutions Market Attractiveness Analysis by Country, 2016-2032
  - Figure 55: Asia-Pacific Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Figure 56: Asia-Pacific Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 57: Asia-Pacific Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Figure 58: Asia-Pacific Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Figure 59: Asia-Pacific Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 60: Asia-Pacific Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Figure 61: Asia-Pacific Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Figure 62: Asia-Pacific Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Figure 63: Asia-Pacific Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Figure 64: Asia-Pacific Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Figure 65: South America Intravenous Solutions Revenue (US$ Mn) Market Share by Productin 2022
  - Figure 66: South America Intravenous Solutions Market Attractiveness Analysis by Product, 2016-2032
  - Figure 67: South America Intravenous Solutions Revenue (US$ Mn) Market Share by Nutrientin 2022
  - Figure 68: South America Intravenous Solutions Market Attractiveness Analysis by Nutrient, 2016-2032
  - Figure 69: South America Intravenous Solutions Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 70: South America Intravenous Solutions Market Attractiveness Analysis by Country, 2016-2032
  - Figure 71: South America Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Figure 72: South America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 73: South America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Figure 74: South America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Figure 75: South America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 76: South America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Figure 77: South America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Figure 78: South America Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Figure 79: South America Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Figure 80: South America Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Figure 81: Middle East and Africa Intravenous Solutions Revenue (US$ Mn) Market Share by Productin 2022
  - Figure 82: Middle East and Africa Intravenous Solutions Market Attractiveness Analysis by Product, 2016-2032
  - Figure 83: Middle East and Africa Intravenous Solutions Revenue (US$ Mn) Market Share by Nutrientin 2022
  - Figure 84: Middle East and Africa Intravenous Solutions Market Attractiveness Analysis by Nutrient, 2016-2032
  - Figure 85: Middle East and Africa Intravenous Solutions Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 86: Middle East and Africa Intravenous Solutions Market Attractiveness Analysis by Country, 2016-2032
  - Figure 87: Middle East and Africa Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Figure 88: Middle East and Africa Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 89: Middle East and Africa Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Figure 90: Middle East and Africa Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Figure 91: Middle East and Africa Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 92: Middle East and Africa Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Figure 93: Middle East and Africa Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Figure 94: Middle East and Africa Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Figure 95: Middle East and Africa Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Figure 96: Middle East and Africa Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
- List of Tables
  - Table 1: Global Intravenous Solutions Market Comparison by Product (2016-2032)
  - Table 2: Global Intravenous Solutions Market Comparison by Nutrient (2016-2032)
  - Table 3: Global Intravenous Solutions Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Table 4: Global Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Table 5: Global Intravenous Solutions Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Table 6: Global Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Table 7: Global Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Table 8: Global Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
  - Table 9: Global Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Table 10: Global Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Table 11: Global Intravenous Solutions Market Share Comparison by Region (2016-2032)
  - Table 12: Global Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Table 13: Global Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Table 14: North America Intravenous Solutions Market Comparison by Nutrient (2016-2032)
  - Table 15: North America Intravenous Solutions Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 16: North America Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Table 17: North America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 18: North America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Table 19: North America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Table 20: North America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 21: North America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Table 22: North America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Table 23: North America Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Table 24: North America Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Table 25: North America Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Table 26: Europe Intravenous Solutions Market Comparison by Product (2016-2032)
  - Table 27: Europe Intravenous Solutions Market Comparison by Nutrient (2016-2032)
  - Table 28: Europe Intravenous Solutions Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 29: Europe Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Table 30: Europe Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 31: Europe Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Table 32: Europe Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Table 33: Europe Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 34: Europe Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Table 35: Europe Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Table 36: Europe Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Table 37: Europe Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Table 38: Europe Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Table 39: Asia-Pacific Intravenous Solutions Market Comparison by Product (2016-2032)
  - Table 40: Asia-Pacific Intravenous Solutions Market Comparison by Nutrient (2016-2032)
  - Table 41: Asia-Pacific Intravenous Solutions Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 42: Asia-Pacific Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Table 43: Asia-Pacific Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 44: Asia-Pacific Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Table 45: Asia-Pacific Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Table 46: Asia-Pacific Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 47: Asia-Pacific Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Table 48: Asia-Pacific Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Table 49: Asia-Pacific Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Table 50: Asia-Pacific Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Table 51: Asia-Pacific Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Table 52: South America Intravenous Solutions Market Comparison by Product (2016-2032)
  - Table 53: South America Intravenous Solutions Market Comparison by Nutrient (2016-2032)
  - Table 54: South America Intravenous Solutions Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 55: South America Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Table 56: South America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 57: South America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Table 58: South America Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Table 59: South America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 60: South America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Table 61: South America Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Table 62: South America Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Table 63: South America Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Table 64: South America Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
  - Table 65: Middle East and Africa Intravenous Solutions Market Comparison by Product (2016-2032)
  - Table 66: Middle East and Africa Intravenous Solutions Market Comparison by Nutrient (2016-2032)
  - Table 67: Middle East and Africa Intravenous Solutions Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 68: Middle East and Africa Intravenous Solutions Market Revenue (US$ Mn) (2016-2032)
  - Table 69: Middle East and Africa Intravenous Solutions Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 70: Middle East and Africa Intravenous Solutions Market Revenue (US$ Mn) Comparison by Product (2016-2032)
  - Table 71: Middle East and Africa Intravenous Solutions Market Revenue (US$ Mn) Comparison by Nutrient (2016-2032)
  - Table 72: Middle East and Africa Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 73: Middle East and Africa Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Product (2016-2032)
  - Table 74: Middle East and Africa Intravenous Solutions Market Y-o-Y Growth Rate Comparison by Nutrient (2016-2032)
  - Table 75: Middle East and Africa Intravenous Solutions Market Share Comparison by Country (2016-2032)
  - Table 76: Middle East and Africa Intravenous Solutions Market Share Comparison by Product (2016-2032)
  - Table 77: Middle East and Africa Intravenous Solutions Market Share Comparison by Nutrient (2016-2032)
- Fresenius Kabi AG
- Pfizer, Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Baxter International Inc Company Profile
- B. Braun Melsungen AG Company Profile
- Vifor Pharma Management Ltd.
- JW Life Science
- Amanta Healthcare
- ICU Medical Inc.
- Grifols, S.A.
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)